Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Schultz

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cancer Research : MCR|August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 InhibitionTeena Dhir, Christopher W Schultz, Aditi Jain, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumorNobuyuki Takahashi, Lorinc Pongor, Shivam P Agrawal, et al.
Genome Medicine|February 26, 2025
Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumorNobuyuki Takahashi, Lorinc Pongor, Shivam P Agrawal, et al.
Nature Communications|April 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived modelsDelphine Lissa, Nobuyuki Takahashi, Parth Desai, et al.
Translational Oncology|April 2, 2023
A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumorsGrace A McCarthy, Aditi Jain, Roberto Di Niro, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|June 19, 2020
Validation of American Joint Committee on Cancer 8<sup>th</sup> edition of TNM staging in resected distal pancreatic cancerFeng Yin, Mohammed Saad, Hao Xie, et al.
Gastroenterology Report|May 24, 2021
Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancerFeng Yin, Mohammed Saad, Jingmei Lin, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Cancer Biology & Therapy|March 11, 2021
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical modelChristopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, et al.
EMBO Molecular Medicine|July 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer Research : MCR|August 7, 2019
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 InhibitionTeena Dhir, Christopher W Schultz, Aditi Jain, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Genomic alterations and transcriptional phenotypes in circulating tumor DNA and matched metastatic tumorNobuyuki Takahashi, Lorinc Pongor, Shivam P Agrawal, et al.
Genome Medicine|February 26, 2025
Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumorNobuyuki Takahashi, Lorinc Pongor, Shivam P Agrawal, et al.
Nature Communications|April 20, 2022
Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived modelsDelphine Lissa, Nobuyuki Takahashi, Parth Desai, et al.
Translational Oncology|April 2, 2023
A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumorsGrace A McCarthy, Aditi Jain, Roberto Di Niro, et al.
World Journal of Gastrointestinal Pharmacology and Therapeutics|June 19, 2020
Validation of American Joint Committee on Cancer 8<sup>th</sup> edition of TNM staging in resected distal pancreatic cancerFeng Yin, Mohammed Saad, Hao Xie, et al.
Gastroenterology Report|May 24, 2021
Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancerFeng Yin, Mohammed Saad, Jingmei Lin, et al.
Molecular and Cellular Biology|June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal AdenocarcinomaSamantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Cancer Biology & Therapy|March 11, 2021
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical modelChristopher W Schultz, Gorka Ruiz de Garibay, Anika Langer, et al.
EMBO Molecular Medicine|July 26, 2023
ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancerChristopher W Schultz, Yang Zhang, Rajaa Elmeskini, et al.
Pageof 4